Tag Archives: AEP

Top Blue Chip Stocks To Own For 2018

I really have an active dislike for the term “blue-chip stock.”

Plain and simple: the term is outdated. A lot of large-cap familiar names are still called “blue-chip stock” when they are nothing of the kind. If you can’t rid the term “blue-chip stock” from your lexicon, then it should at least apply to a whole new stream of companies.

“Blue-chip stock” used to refer to companies that were constantly growing earnings in the high single-digits or more in terms of percentage, had a fortress balance sheet and were constantly innovating. The seven stocks I’m about to talk about have either none of these traits or, at best, have a really solid balance sheet.

Compare Brokers

Blue-Chip Stocks That Aren’t Really Blue Chips: IBM

Let’s start with International Business Machines Corp. (NYSE:IBM), a former blue-chip stock, which the world has left so far behind that even Warren Buffett sold out of his position.

Top Blue Chip Stocks To Own For 2018: Tennessee Valley Authority(TVE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tamarack-Valley-Energy (CVE:TVE) had its price objective raised by equities research analysts at BMO Capital Markets from C$3.75 to C$4.50 in a research note issued on Friday. BMO Capital Markets’ target price points to a potential downside of 82.02% from the stock’s current price.

Top Blue Chip Stocks To Own For 2018: Apricus Biosciences, Inc(APRI)

Advisors’ Opinion:

  • [By Paul Ausick]

    Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.

  • [By William Romov]

    California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).

  • [By Chris Lange]

    Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDAs review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.

Top Blue Chip Stocks To Own For 2018: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By ]

    In his second “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Reuben Gregg Brewer]

    On the surface, American Electric Power Company, Inc. (NYSE:AEP) is a pretty simple business to understand — it generates and distributes electricity. But when you dig under the surface a little, you start to see that its business has changed materially in recent years. More important, AEP is now positioned to take advantage of industry shifts taking place in the power sector. Here’s how AEP makes most of its money and why its prospects for slow and steady growth are so strong.

Top Blue Chip Stocks To Own For 2018: BioMarin Pharmaceutical Inc.(BMRN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the headlines that may have impacted Accern Sentiment’s scoring:

    Get BioMarin Pharmaceutical alerts:

    BioMarin Pharmaceutical (BMRN) Director Sells $318,750.00 in Stock (americanbankingnews.com) BioMarin Pharmaceutical (BMRN) Set to Announce Quarterly Earnings on Wednesday (americanbankingnews.com) BioMarin Pharmaceutical’s (BMRN) “Outperform” Rating Reiterated at BMO Capital Markets (americanbankingnews.com) Three healthcare stocks driving the gene therapy momentum (ca.finance.yahoo.com) 4 Red-Hot Biotech Stocks to Buy Before Earnings (247wallst.com)

    Shares of BioMarin Pharmaceutical stock traded down $1.32 on Friday, hitting $82.30. 2,278,721 shares of the company’s stock traded hands, compared to its average volume of 1,207,934. BioMarin Pharmaceutical has a one year low of $75.81 and a one year high of $100.51. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.70 and a quick ratio of 2.12. The firm has a market cap of $14,490.73, a price-to-earnings ratio of -122.84 and a beta of 1.69.

  • [By ]

    This week we get our first look at quarterly numbers from major drug and biotech giants such as AbbVie (ABBV)  , Amgen (AMGN)  , Biogen (BIIB) , Biomarin Pharmaceuticals (BMRN)  and Action Alerts PLUS holding Eli Lilly (LLY) , which all provide the market a glimpse of how the first quarter was for the industry over the next few days,” according to Real Money Pro columnist Bret Jensen.

  • [By ]

    BioMarin Pharmaceutical (Nasdaq: BMRN) is a leader in the orphan drug category (drugs used to treat rare diseases), which gives it extended protection and a longer sales trajectory versus other pharmaceuticals. The company is expected to bring its PKU treatment Pegvaliase to market this year to add significantly to sales and blockbusters Vosoritide and Valrox could come to market within the next two years.

  • [By Chris Lange]

    BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is expected to report its most recent quarterly results on February 22. The consensus estimates from Thomson Reuters are calling for a net loss of $0.24 per share on $357.49 million in revenue. The same period of last year had a net loss of $0.53 per share and $300.09 million in revenue. Shares of BioMarin were last seen at $84.98, with a consensus price target of $110.32 and a 52-week range of $78.50 to $100.51.

  • [By Chris Lange]

    BioMarin Pharmaceutical Inc.’s (NASDAQ: BMRN) first-quarter results are due late on Wednesday. The consensus forecast calls for a net loss of $0.18 per share and revenue of $348.57 million. The shares ended last week at $82.30. The consensus analyst target is $114.30. The 52-week trading range is $75.81 to $100.51.

Hot Stocks For 2018

It was big newswhen outstanding student loan debt surpassed credit card debt and then later exceeded $1 trillion for the first time. That shocking statistickeeps climbing, with no sign of slowing down: Americans now have more than $1.4 trillion in unpaid education debt, according to the Federal Reserve.

Meanwhile, college-bound kids and their families try to avoid going into debt by heeding advice like save more, apply for scholarships or go to a cheaper school. Of course, none of those address the majorissue of rising costs that have far outpaced wage growth.

Its smart to avoid student loan debt if you can, because those loans affect your creditand your financial future. (You can see how much by checking your free credit scores on Credit.com.) However, strategically choosing a school isnt quite asstraightforward as comparing tuition and fees.

Hot Stocks For 2018: USG Corporation(USG)

Advisors’ Opinion:

  • [By Jordan Wathen]

    As USG Corporation (NYSE:USG) drags its feet on an offer to sell the company for $42 per share, Berkshire intends to use its 30.8% ownership stake to motivate its top brass to make a deal. Berkshire told Bloomberg it intends to vote its shares against USG’s board members who are up for re-election at this year’s annual meeting, a clear message that Buffett is ready to cash in, even if USG’s management and board are not.

  • [By Dan Caplinger]

    Warren Buffett likes to hold his stock positions for the long run, and his experience with USG (NYSE:USG) has been typical of his other long-term investments. The Oracle of Omaha started buying shares of the manufacturer of Sheetrock drywall and other building materials back in 2000, accumulating a sizable stake that has ballooned to more than 30% of the company. USG ended up going through bankruptcy in order to get a handle on its asbestos liability claims, but thanks largely to Buffett’s involvement, the building materials company not only survived bankruptcy but also saw share prices soar briefly on hopes that USG would once again fully participate in the then-strong housing boom.

  • [By Stephan Byrd]

    ValuEngine upgraded shares of USG (NYSE:USG) from a buy rating to a strong-buy rating in a report published on Tuesday.

    A number of other research analysts have also recently weighed in on the stock. Credit Suisse Group upgraded shares of USG from an underperform rating to a neutral rating and dropped their target price for the company from $35.00 to $24.00 in a research note on Friday, April 27th. Jefferies Group reiterated a hold rating and issued a $40.00 target price on shares of USG in a research note on Monday, April 23rd. SunTrust Banks boosted their target price on shares of USG from $42.00 to $44.00 and gave the company a hold rating in a research note on Tuesday, April 17th. Buckingham Research boosted their target price on shares of USG from $34.00 to $42.00 and gave the company a neutral rating in a research note on Monday, April 16th. Finally, Nomura boosted their target price on shares of USG from $39.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, March 27th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of $39.00.

Hot Stocks For 2018: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Lexicon Pharmaceuticals (NASDAQ:LXRX) – Analysts at Wedbush issued their Q1 2019 earnings per share (EPS) estimates for Lexicon Pharmaceuticals in a note issued to investors on Monday, May 7th. Wedbush analyst L. Moussatos expects that the biopharmaceutical company will earn ($0.28) per share for the quarter. Wedbush currently has a “Outperform” rating and a $40.00 target price on the stock. Wedbush also issued estimates for Lexicon Pharmaceuticals’ Q2 2019 earnings at ($0.25) EPS, Q3 2019 earnings at ($0.13) EPS, Q4 2019 earnings at ($0.06) EPS, FY2020 earnings at $0.53 EPS, FY2021 earnings at $2.22 EPS and FY2022 earnings at $3.81 EPS.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Stocks For 2018: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By Reuben Gregg Brewer]

    On the surface, American Electric Power Company, Inc. (NYSE:AEP) is a pretty simple business to understand — it generates and distributes electricity. But when you dig under the surface a little, you start to see that its business has changed materially in recent years. More important, AEP is now positioned to take advantage of industry shifts taking place in the power sector. Here’s how AEP makes most of its money and why its prospects for slow and steady growth are so strong.

  • [By ]

    In an “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

  • [By ]

    In the Lightning Round, Cramer was bullish on Consolidated Edison (ED) , American Electric Power (AEP) and Clorox (CLX) .

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.

Top 5 Medical Stocks To Own For 2019

Massachusetts Financial Services Co. MA trimmed its holdings in shares of Zimmer Biomet (NYSE:ZBH) by 8.5% during the first quarter, HoldingsChannel reports. The institutional investor owned 15,053,800 shares of the medical equipment provider’s stock after selling 1,404,161 shares during the quarter. Massachusetts Financial Services Co. MA owned 0.07% of Zimmer Biomet worth $1,641,467,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the business. Longview Partners Guernsey LTD boosted its holdings in shares of Zimmer Biomet by 6.9% during the 4th quarter. Longview Partners Guernsey LTD now owns 8,027,808 shares of the medical equipment provider’s stock worth $968,716,000 after buying an additional 521,124 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Zimmer Biomet by 5.5% during the 1st quarter. American Century Companies Inc. now owns 5,039,181 shares of the medical equipment provider’s stock worth $549,472,000 after buying an additional 261,784 shares in the last quarter. OppenheimerFunds Inc. boosted its holdings in shares of Zimmer Biomet by 14.8% during the 4th quarter. OppenheimerFunds Inc. now owns 2,644,596 shares of the medical equipment provider’s stock worth $319,124,000 after buying an additional 340,845 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Zimmer Biomet by 13.1% during the 1st quarter. Wells Fargo & Company MN now owns 2,312,443 shares of the medical equipment provider’s stock worth $252,149,000 after buying an additional 268,068 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of Zimmer Biomet by 4.9% during the 4th quarter. Geode Capital Management LLC now owns 2,175,052 shares of the medical equipment provider’s stock worth $261,927,000 after buying an additional 101,575 shares in the last quarter. Hedge funds and other institutional investors own 86.62% of the company’s stock.

Top 5 Medical Stocks To Own For 2019: Avery Dennison Corporation(AVY)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Avery Dennison alerts:

    Avery Dennison (AVY) Shares Cross Below 200 DMA (nasdaq.com) Avery Dennison (AVY) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Concern in Framingham about environmental contamination (metrowestdailynews.com) Avery Dennison (AVY) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com) Avery Dennison (AVY) Upgraded at Zacks Investment Research (americanbankingnews.com)

    Several equities research analysts recently commented on AVY shares. Citigroup dropped their price objective on Avery Dennison from $140.00 to $125.00 and set a “buy” rating on the stock in a research report on Thursday, April 5th. Zacks Investment Research raised Avery Dennison from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research report on Monday, February 5th. UBS started coverage on Avery Dennison in a research report on Thursday, January 18th. They set a “buy” rating and a $135.00 price objective on the stock. Bank of America increased their price objective on Avery Dennison from $128.00 to $133.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Finally, KeyCorp reaffirmed a “hold” rating on shares of Avery Dennison in a research report on Wednesday, April 25th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $123.00.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Stephan Byrd]

    Strategy Asset Managers LLC acquired a new stake in Avery Dennison (NYSE:AVY) during the first quarter, HoldingsChannel.com reports. The firm acquired 23,500 shares of the industrial products company’s stock, valued at approximately $2,497,000.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Own For 2019: Cidara Therapeutics, Inc.(CDTX)

Advisors’ Opinion:

  • [By Chris Lange]

    Cidara Therapeutics Inc. (NASDAQ: CDTX) shares took a big step back on Monday, despite the firm reporting positive midstage results. Specifically, Cidara reported positive topline results from its Phase 2 Strive clinical trial of its lead antifungal candidate rezafungin acetate.

  • [By Joseph Griffin]

    Cidara Therapeutics (NASDAQ:CDTX) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.70) by ($0.10), Bloomberg Earnings reports.

Top 5 Medical Stocks To Own For 2019: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.

  • [By Reuben Gregg Brewer]

    On the surface, American Electric Power Company, Inc. (NYSE:AEP) is a pretty simple business to understand — it generates and distributes electricity. But when you dig under the surface a little, you start to see that its business has changed materially in recent years. More important, AEP is now positioned to take advantage of industry shifts taking place in the power sector. Here’s how AEP makes most of its money and why its prospects for slow and steady growth are so strong.

  • [By ]

    Consolidated Edison (ED) : “Mr. Ed is a buy, buy, buy. I also like American Electric Power (AEP) .”

    Clorox (CLX) : “Clorox is caught up in the Treasury yield vortex. I say you buy some and when it comes down you buy more.”

  • [By Logan Wallace]

    Stephens Inc. AR decreased its position in American Electric Power (NYSE:AEP) by 10.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,738 shares of the utilities provider’s stock after selling 4,742 shares during the quarter. Stephens Inc. AR’s holdings in American Electric Power were worth $2,657,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 5 Medical Stocks To Own For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Own For 2019: Haverty Furniture Companies, Inc.(HVT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Havertys (NYSE:HVT) – Stock analysts at KeyCorp dropped their Q2 2018 earnings per share estimates for Havertys in a research report issued on Wednesday, May 2nd. KeyCorp analyst B. Thomas now anticipates that the company will post earnings per share of $0.29 for the quarter, down from their previous forecast of $0.31. KeyCorp also issued estimates for Havertys’ Q3 2018 earnings at $0.39 EPS and Q4 2018 earnings at $0.45 EPS.

Top Blue Chip Stocks To Watch For 2018

Investors can add all sorts of investments to an IRA, but many financial advisors will suggest sticking with conservative dividend stocks. The reason is simple — blue chip income generators generally bounce back from big market crashes, and the compounding effect of reinvested dividends can deliver massive returns over several decades.

At first glance, tobacco giant Altria (NYSE:MO) seems like a great stock for an IRA. Its flagship Marlboro brand dominates the U.S. market, it pays a hefty forward dividend yield of 3.4%, and it’s hiked that dividend every year since it spun off itsoverseas business as Philip Morris International (NYSE:PM) in 2008. But if you gaze further into Altria’s future, you’ll realize that it’s not a great long-term pick for your IRA at all.

Image source: Getty Images.

Why Altria seems like a good IRA stock

Altria shares have rallied 20% over the past 12 months, outperforming Philip Morris’ 15% rally but slightly underperforming the S&P 500’s 25% gain. Much of that growth can be attributed to two factors — a flight to high-yielding dividend stocks in a low interest rate environment and Altria’s purely domestic business insulating it from the currency headwinds which gobbled up Philip Morris’ overseas gains.

Top Blue Chip Stocks To Watch For 2018: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By ]

    In his second “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.

  • [By ]

    In the Lightning Round, Cramer was bullish on Consolidated Edison (ED) , American Electric Power (AEP) and Clorox (CLX) .

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter
  • [By ]

    In an “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

Top Blue Chip Stocks To Watch For 2018: Northern Trust Corporation(NTRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Timber Hill LLC purchased a new position in shares of Northern Trust (NASDAQ:NTRS) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 17,072 shares of the asset manager’s stock, valued at approximately $1,761,000.

  • [By Stephan Byrd]

    Northern Trust (NASDAQ:NTRS) insider Jeffrey D. Cohodes sold 14,979 shares of the firm’s stock in a transaction dated Monday, May 7th. The stock was sold at an average price of $105.15, for a total value of $1,575,041.85. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Ethan Ryder]

    Northern Trust (NASDAQ:NTRS) last announced its quarterly earnings results on Tuesday, April 17th. The asset manager reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.16. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.45 billion. Northern Trust had a return on equity of 13.87% and a net margin of 21.84%. Northern Trust’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.09 earnings per share. analysts anticipate that Northern Trust will post 6.49 EPS for the current year.

  • [By Logan Wallace]

    Northern Trust (NASDAQ:NTRS)‘s stock had its “buy” rating reaffirmed by analysts at Royal Bank of Canada in a research report issued on Wednesday.

Top Blue Chip Stocks To Watch For 2018: Nevro Corp.(NVRO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Nevro (NYSE:NVRO) released its quarterly earnings results on Monday. The medical equipment provider reported ($0.59) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.32) by ($0.27), Bloomberg Earnings reports. Nevro had a negative net margin of 11.22% and a negative return on equity of 15.01%.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Nevro Corp. (NASDAQ: NVRO) fell 11.6 percent to $81.58 in pre-market trading after reporting wider-than-expected Q1 loss.
    Hertz Global Holdings, Inc. (NYSE: HTZ) shares fell 8.3 percent to $20.33 in pre-market trading after the company reported a wider-than-expected loss for its first quarter.
    Zillow Group, Inc. (NASDAQ: Z) fell 7.5 percent to $51.74 in pre-market trading. Zillow reported upbeat earnings for its first quarter, but issued weak sales guidance for the second quarter.
    Sanchez Energy Corporation (NYSE: SN) fell 7.2 percent to $3.11 in pre-market trading after reporting wider-than-expected Q1 loss.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 5.5 percent to $4.14 in pre-market trading after rising 11.17 percent on Monday.
    Albemarle Corporation (NYSE: ALB) fell 5.1 percent to $95.00 in pre-market trading. Albemarle declared a quarterly dividend of $0.335 per share.
    Tata Motors Limited (NYSE: TTM) fell 4.8 percent to $23.80 in pre-market trading.
    Ormat Technologies, Inc. (NYSE: ORA) fell 4.5 percent to $57.14 in pre-market trading after reporting Q1 results.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares fell 4.3 percent to $2.25 in pre-market trading after gaining 1.73 percent on Monday.
    51job, Inc. (NASDAQ: JOBS) shares fell 4.2 percent to $93 in pre-market trading after rising 3.55 percent on Monday

  • [By Lisa Levin]

    Nevro Corp. (NASDAQ: NVRO) shares dropped 14 percent to $79.35 after reporting wider-than-expected Q1 loss.

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 11 percent to $19.77 after the company reported a wider-than-expected loss for its first quarter.

  • [By Ethan Ryder]

    Nevro (NYSE:NVRO) had its price objective cut by Canaccord Genuity from $110.00 to $102.00 in a note issued to investors on Tuesday, Marketbeat Ratings reports. The brokerage currently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity’s price target indicates a potential upside of 34.87% from the stock’s current price.

Top Blue Chip Stocks To Watch For 2018: Baidu Inc.(BIDU)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    On this episode of Industry Focus: Tech, host Dylan Lewis is joined by Fool.com contributor Danny Vena to discuss how iQiyi’s(NASDAQ:IQ) connection to Baidu(NASDAQ:BIDU) may give investors an advantage compared to a traditional start-up.

  • [By ]

    In the Lightning Round, Cramer was bullish on Walgreens Boots Alliance (WBA) , Arena Pharmaceuticals (ARNA) , Dominion Energy (D) , Idexx Laboratories (IDXX) , GlaxoSmithKline (GSK) , Baidu.com (BIDU) , Baozun (BZUN) and Alibaba (BABA) .

  • [By Danny Vena]

    Chinese streaming giant iQiyi Inc. (NASDAQ:IQ)was recently spun off from China’s search leader Baidu Inc. (NASDAQ:BIDU), raising an estimated $2.25 billion in the process.

  • [By Leo Sun]

    That expansion can be hard to keep track of, but investors should recognize the five companies which Tencent could hurt: NetEase (NASDAQ:NTES), Weibo (NASDAQ:WB), Baidu (NASDAQ:BIDU), iQiyi (NASDAQ:IQ), and Alibaba (NYSE:BABA).

  • [By Motley Fool Staff]

    In this segment of the Motley Fool Moneypodcast, host Chris Hill and senior Fool analysts Jason Moser, David Kretzmann, and Jeff Fischer put Baidu(NASDAQ:BIDU) under the microscope. The Chinese search leader has a massive presence in the world’s most populous market, and with revenue up 31%, it’s apparent that it is putting its troubles with the government in Beijing in the rearview mirror. But the stock is still only trading for six times revenue. Time to give it a look?

  • [By Motley Fool Staff]

    Chris Hill: Now that iQiyi is public — you’ve talked about this before, is this of interest to you? Is this a stock you’ve already bought, or it’s on the watch list? And for those who don’t know, iQiyi was essentially spun out of Baidu (NASDAQ:BIDU). So, the Google of China spins out the Netflix of China. And as you said before, it seems like, if nothing else, it’s a win for Baidu shareholders, because Baidu still has the ownership stake.

Top 5 Casino Stocks To Buy Right Now

Earnings season can be one of the most lucrative times of the year for stock traders.

Just take a look at Money Morning Quantitative Specialist Chris Johnson’s track record.

He banked a 224% profit on Best Buy Co. (NYSE: BBY) after its May 2017 earnings report, 151% on Deere & Co. (NYSE: DE) in May 2017, and another 100% gainer in only 18 days after Alibaba Group Holding Ltd. (NYSE: BABA) reported earnings in August 2017.

And that’s just the beginning of the earnings play potential with Chris’ “Share Score.”

For untrained investors, options trading can be like placing a bet in a Vegas casino. You think the stock is going to move a certain amount higher or lower, and you put your money behind your prediction.

But that’s not the case with Chris’ system.

Chris identifies stocks with the potential to pop that hapless traders are betting against. Then he cleans up.

And earnings season is the perfect time to use his strategy.

Top 5 Casino Stocks To Buy Right Now: Microchip Technology Incorporated(MCHP)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Shanthi Rexaline]

    Morgan Stanley's Joseph Moore previewed earnings reports from MPINJ Inc (NASDAQ: PI), Microchip Technology Inc. (NASDAQ: MCHP) and NVIDIA Corporation (NASDAQ: NVDA). Morgan Stanley has the following ratings on the companies:

  • [By Stephan Byrd]

    Microchip Technology (NASDAQ:MCHP) had its price objective increased by Morgan Stanley from $96.00 to $97.00 in a research report report published on Wednesday morning. The brokerage currently has an equal weight rating on the semiconductor company’s stock.

  • [By Lee Jackson]

    This company is a huge Internet of Things benefactor. Microchip Technology Inc. (NASDAQ: MCHP) is a leading provider of microcontroller, mixed-signal, analog and flash-IP solutions, providing low-risk product development, lower total system cost and faster time to market for thousands of diverse customer applications worldwide.

  • [By ]

    Though concerns have been raised that the analog and MCU markets are at risk of seeing an inventory correction (they haven’t had a major one in a while), given signs of excessive ordering and stretched lead times, TI and STMicro’s numbers suggest conditions remain good for now. That’s particularly true in industrial and auto markets where trends such as factory automation, ADAS adoption and electric/hybrid car sales are boosting chip demand. Several other analog/MCU firms, including Microchip (MCHP) , ON Semiconductor (ON) , Maxim Integrated (MXIM) and NXP Semiconductors (NXPI) , will be reporting soon.

Top 5 Casino Stocks To Buy Right Now: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Consolidated Edison (ED) , American Electric Power (AEP) and Clorox (CLX) .

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By ]

    In an “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.

  • [By Logan Wallace]

    Stephens Inc. AR decreased its position in American Electric Power (NYSE:AEP) by 10.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,738 shares of the utilities provider’s stock after selling 4,742 shares during the quarter. Stephens Inc. AR’s holdings in American Electric Power were worth $2,657,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By ]

    Consolidated Edison (ED) : “Mr. Ed is a buy, buy, buy. I also like American Electric Power (AEP) .”

    Clorox (CLX) : “Clorox is caught up in the Treasury yield vortex. I say you buy some and when it comes down you buy more.”

  • [By ]

    In his second “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

Top 5 Casino Stocks To Buy Right Now: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Rick Munarriz]

    The market isn’t warming up toSohu.com’s(NASDAQ:SOHU)latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning.

  • [By Rick Munarriz]

    I’ve been coveringSohu.com (NASDAQ:SOHU)for awhile, so when the Chinese internet pioneer announced plans tospin off Sogou, I was more than a little interested. Sogou has been the main growth driver at Sohu for years. With Sohu’s online advertising business meandering and its internet gaming business proving volatile, search has been its crown jewel.

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

Top 5 Casino Stocks To Buy Right Now: Equifax, Inc.(EFX)

Advisors’ Opinion:

  • [By Money Morning News Team]

    In just the first six months of 2017, there were 230% more data breaches in the United States than the prior year. Some of the major U.S. companies that experienced breaches include Verizon Communications Inc. (NYSE: VZ), Microsoft Corp. (Nasdaq: MSFT), and Equifax Inc. (NYSE: EFX).

  • [By ]

    Walmart is trying out a similar tactic with pork supply chains in China, but it’s far from the only company dipping its toe in the space. Other companies are testing blockchain’s potential for their logistics — everything from airplane parts, cargo shipments, medical records and even digital identities for refugees who lack official documents. Imagine no longer having a social security card, but a digital identity that couldn’t be hacked. We wouldn’t have to worry about data breaches like the recent one at Equifax (NYSE: EFX).

Top 5 Casino Stocks To Buy Right Now: Franklin Covey Company(FC)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Osmium Partners, LLC’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Osmium+Partners%2C+LLC

    These are the top 5 holdings of Osmium Partners, LLCRosetta Stone Inc (RST) – 1,912,104 shares, 16.55% of the total portfolio. Shares reduced by 3.7%Tucows Inc (TCX) – 333,179 shares, 12.28% of the total portfolio. Shares added by 0.62%Franklin Covey Co (FC) – 618,000 shares, 10.94% of the total portfolio. Franklin Covey Co (FC) – 580,490 shares, 10.28% of the total portfolio. Shares added by 9.77%Leaf Group Ltd (LF

Top Undervalued Stocks For 2018

We initiate a BUY rating on ATN International, Inc. (NASDAQ:ATNI), and our target price is $74.9. ATNI is an expanding company investing worldwide both in telecommunications and renewable energy industries. Its international and multi-industrial investing strategies successfully overcome the decline in U.S. telecommunications business, which ensures a stable growth rate for the company. The stable growth and strong financial capability in turn enable the company for further investments. Overall, we think the stock price is currently undervalued.

Company Highlights

(1) ATNI has made two acquisitions to strengthen its presence in the Caribbean and has started a large-scale solar project in India. These new ventures should enable the company to generate a new source of free cash flow after its prediction of breakeven by the first half of 2017.

(2) The U.S. telecom segment is shrinking due to lower wholesale roaming data rate, partially offset by an increase in data volume. We don’t see rapid growth in this segment.

Top Undervalued Stocks For 2018: NTT DOCOMO, Inc(DCM)

Advisors’ Opinion:

  • [By Logan Wallace]

    Bank of Hawaii bought a new position in NTT Docomo Inc (NYSE:DCM) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,664 shares of the technology company’s stock, valued at approximately $222,000.

Top Undervalued Stocks For 2018: ON Semiconductor Corporation(ON)

Advisors’ Opinion:

  • [By ]

    Though concerns have been raised that the analog and MCU markets are at risk of seeing an inventory correction (they haven’t had a major one in a while), given signs of excessive ordering and stretched lead times, TI and STMicro’s numbers suggest conditions remain good for now. That’s particularly true in industrial and auto markets where trends such as factory automation, ADAS adoption and electric/hybrid car sales are boosting chip demand. Several other analog/MCU firms, including Microchip (MCHP) , ON Semiconductor (ON) , Maxim Integrated (MXIM) and NXP Semiconductors (NXPI) , will be reporting soon.

  • [By Lee Jackson]

    Aggressive accounts may want to look at this smaller cap play. ON Semiconductor Corp. (NASDAQ: ON) is a vendor of analog power management, analog signal conditioning, standard logic integrated circuits and discrete chips into the automotive, communications, computing, consumer, industrial and medical applications. The company is in the midst of a transformation from a seller of commodity discrete chips into higher value added analog integrated circuits, both through organic growth and acquisitions.

Top Undervalued Stocks For 2018: Exelixis, Inc.(EXEL)

Advisors’ Opinion:

  • [By ]

    Exelixis (EXEL) : “Biotechs are not working so I’m not going to recommend it.”

    Moneygram (MGI) : “No, you need quality and this one doesn’t have it.”

  • [By Brian Orelli]

    After a disappointing fourth quarter, Exelixis (NASDAQ:EXEL) reaccelerated growth in the first quarter, bolstered by a new approval for Cabometyx in previously untreated advanced renal cell carcinoma (RCC), also known as kidney cancer.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

  • [By Joseph Griffin]

    Exelixis (NASDAQ:EXEL) – Equities researchers at Oppenheimer raised their Q2 2018 earnings per share (EPS) estimates for Exelixis in a report issued on Wednesday, May 2nd. Oppenheimer analyst L. Cann now forecasts that the biotechnology company will post earnings of $0.11 per share for the quarter, up from their prior forecast of $0.09. Oppenheimer currently has a “Outperform” rating and a $40.00 target price on the stock. Oppenheimer also issued estimates for Exelixis’ Q3 2018 earnings at $0.13 EPS, Q4 2018 earnings at $0.14 EPS and FY2018 earnings at $0.74 EPS.

Top Undervalued Stocks For 2018: Insmed, Inc.(INSM)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Insmed Inc. (NASDAQ: INSM) was raised to Outperform from Neutral at Credit Suisse.

    Lululemon Athletica Inc. (NASDAQ: LULU) was downgraded to Hold from Buy at Needham, based on the run-up in shares and on a harder earnings comparison that will be harder to beat. Lululemon was up 1% at $96.31 but was down 2% at $94.30 on Monday. It had a consensus target price of $89.93.

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 78.82 percent to close at $7.26 on Monday.
    GEE Group, Inc. (NYSE: JOB) shares jumped 18 percent to close at $2.36.
    McDermott International, Inc. (NYSE: MDR) climbed 15.7 percent to close at $7.00 after the UK-based offshore oil service company Subsea 7 made an unsolicited bid to buy McDermott for $7 per share. However, the acquisition offer is contingent on McDermot terminating its pending merger with Chicago Bridge & Iron Company.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) gained 17.21 percent to close at $3.61.
    Stars Group Inc. (NASDAQ: TSG) rose 14.16 percent to close at $33.45. Stars Group Inc (NASDAQ: TSG) announced plans to acquire Sky Betting & Gaming for $4.7 billion.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares jumped 12.79 percent to close at $25.58.
    Nautilus, Inc. (NYSE: NLS) shares gained 11.52 percent to close at $15.00. Nautilus is expected to release Q1 results on May 7, 2018. Craig-Hallum initiated coverage on Nautilus with a Buy rating and a $19.00 price target.
    Box, Inc. (NYSE: BOX) rose 10.94 percent to close at $22.91.
    Insmed Incorporated (NASDAQ: INSM) shares rose 10.76 percent to close at $26.05. Credit Suisse upgraded Insmed from Neutral to Outperform.
    NextDecade Corporation (NASDAQ: NEXT) shares rose 10.02 percent to close at $6.48.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) shares gained 8.37 percent to close at $2.46 on Monday after falling 10.98 percent on Friday.
    Cambium Learning Group, Inc. (NASDAQ: ABCD) shares gained 7.81 percent to close at $11.11.
    Vectren Corporation (NYSE: VVC) shares rose 7.26 percent to close at $70.31. CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren for $72 per share in cash.
    Tennant Company (NYSE: TNC) rose 6.66 percent to close at $74.45 after the company posted upbeat Q1 results and raised its FY18 earnings outlook.
    Hanesbrands Inc.
  • [By Lisa Levin]

    Insmed Incorporated (NASDAQ: INSM) shares were also up, gaining 9 percent to $25.57. Credit Suisse upgraded Insmed from Neutral to Outperform.

    Equities Trading DOWN

Top Undervalued Stocks For 2018: American Electric Power Company, Inc.(AEP)

Advisors’ Opinion:

  • [By ]

    In an “Executive Decision” segment, Cramer checked in with Nick Akins, chairman, president and CEO of American Electric Power (AEP) , the utility that just posted a two-cents-a-share earnings miss, but reiterated their full-year guidance. Shares of American Electric Power are down 5.1% for the year but yield 3.6%.

  • [By Chris Lange]

    American Electric Power Company, Inc. (NYSE: AEP) shares were recently up 2.5% at $64.93, with a 52-week range of $62.69 to $78.07 and a consensus price target of $74.00.

  • [By Lisa Levin] Companies Reporting Before The Bell
    General Motors Company (NYSE: GM) is projected to report quarterly earnings at $1.24 per share on revenue of $34.66 billion.
    Bristol-Myers Squibb Company (NYSE: BMY) is estimated to report quarterly earnings at $0.85 per share on revenue of $5.24 billion.
    United Parcel Service, Inc. (NYSE: UPS) is expected to report quarterly earnings at $1.55 per share on revenue of $16.44 billion.
    Time Warner Inc. (NYSE: TWX) is projected to report quarterly earnings at $1.74 per share on revenue of $7.91 billion.
    ConocoPhillips (NYSE: COP) is expected to report quarterly earnings at $0.74 per share on revenue of $8.81 billion.
    PepsiCo, Inc. (NYSE: PEP) is expected to report quarterly earnings at $0.93 per share on revenue of $12.4 billion.
    American Airlines Group Inc. (NASDAQ: AAL) is estimated to report quarterly earnings at $0.72 per share on revenue of $10.42 billion.
    Southwest Airlines Co (NYSE: LUV) is expected to report quarterly earnings at $0.74 per share on revenue of $5.01 billion.
    Fiat Chrysler Automobiles N.V. (NYSE: FCAU) is estimated to report quarterly earnings at $0.8 per share on revenue of $34.52 billion.
    Union Pacific Corporation (NYSE: UNP) is projected to report quarterly earnings at $1.66 per share on revenue of $5.38 billion.
    D.R. Horton, Inc. (NYSE: DHI) is expected to report quarterly earnings at $0.85 per share on revenue of $3.76 billion.
    The Hershey Company (NYSE: HSY) is estimated to report quarterly earnings at $1.4 per share on revenue of $1.94 billion.
    Praxair, Inc. (NYSE: PX) is expected to report quarterly earnings at $1.56 per share on revenue of $2.94 billion.
    Altria Group, Inc. (NYSE: MO) is projected to report quarterly earnings at $0.92 per share on revenue of $4.63 billion.
    Shire plc (NASDAQ: SHPG) is estimated to report quarterly earnings at $3.54 per share on revenue of $3.72 billion.
    Oshkosh Corporation (NYSE: OSK) is projected to report quarter